This is the opposite of what you would predict if glucose lowering were the primary mechanism
The Medical Weight Loss and GLP-1 Treatment Program at Taylor Bariatric Institute does not use compounded GLP-1 or GIP/GLP-1 medications under any circumstance because of well-documented concerns regarding safety, potency, consistency, legality, and patient risk
On the other hand, phentermine is more affordable and generally well-tolerated but carries a risk of cardiovascular side effects and is not recommended for those unable to tolerate stimulants
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
These complications can lead to extensive medical treatments, prolonged hospital stays, and a significant reduction in quality of life
That makes it a planning aid, not a replacement for medical advice